MedPath

ong-term outcome of Quality of Life and Symptom Control after participation on the trial: Robotic versus Conventional laparoscopic fundoplication (ROLAF) Trial

Not Applicable
Conditions
K21
Gastro-oesophageal reflux disease
Registration Number
DRKS00014690
Lead Sponsor
Klinik für Allgemein-, Viszeral- un Transplantationschirurgie Universität Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Enrolling by invitation
Sex
All
Target Recruitment
35
Inclusion Criteria

Initial participation in the ROLAF trial, comparing robotic-assisted versus laparoscopic fundoplication.

Exclusion Criteria

No participation on the ROLAF Trial.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Quality Of Life in Reflux and Dyspepsia (QOLRAD) (Questionnaire)<br>- 10 years after initial procedure
Secondary Outcome Measures
NameTimeMethod
- Gastrointestinal Symptom Rating Sclae (GSRS) (Questionnaire)<br>- 10 years after initial procedure
© Copyright 2025. All Rights Reserved by MedPath